Peter Rahal, Co-founder and CEO of RXBar, says the company was founded on the transparency of its ingredients, and that purpose led to a $600 million buyout from Kellogg.
Rahal explains why ever ingredient in every product is in bold letters on the front of the package. When the company started out, "people would be like ‘well what is it?'” So they made the answer easy to find.
Rahal discusses RXBAR's $600 million sale to Kellogg, and the future direction of the company, where he will remain as CEO. We talk about the whirlwind the company's evolution has been, given that it was founded in 2013, when Rahal and his co-founder were both broke. Then we look ahead to what's next for the company after the Kellogg buyout.
Stocks fall for a second day on Wall Street due to weak job data and recession fears. The VIX surges over 60, showing high anxiety and a potential rebound.
A new CEO takes over the embattled planemaker. Plus: Elon picks a fight, the Fed might finally cut rates and Microsoft makes a lot of money but not enough.
